Acute histopathological effects of benzalkonium chloride and absorption enhancers on rat nasal epithelium in vivo

International Journal of Pharmaceutics

Volumn 141, Issue 1-2, 1996, Pages 151-160

  Marttin, E ^a   Verhoef, J C ^a   Romeijn, S G ^a   Zwart, P ^b   Merkus, F W H M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Benzalkonium chloride; Cyclodextrins; Histology; L lysophosphatidylcholine; Nasal absorption enhancers; Sodium glycochoIate

Indexed keywords

2,6 O DIMETHYL BETA CYCLODEXTRIN; BENZALKONIUM CHLORIDE; CYCLODEXTRIN DERIVATIVE; GLYCOCHOLATE SODIUM; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PRESERVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; MALE; MICROSCOPY; MORPHOLOGY; NONHUMAN; NOSE IRRITATION; NOSE MUCOSA; PRIORITY JOURNAL; RAT;

EID: 0030572643     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04632-7     Document Type: Article

References (21)

1. Braat, J.P.M., Ainge, G., Bowles, J.A.K. et al., The lack of effect of benzalkonium chloride on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: a combined functional, light, scanning and transmission electron microscopy. Clin. Exp. All., 25 (1995) 957-965.
2. Chandler, S.G., Illum, L. and Thomas, N.W., Nasal absorption in the rat. I: A method to demonstrate the histological effects of nasal formulations. Int. J. Pharm., 70 (1991a) 19-27.
3. Chandler, S.G., Illum, L. and Thomas, N.W., Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology. Int. J. Pharm., 76 (1991b) 61-70.
4. van de Donk, H.J.M., Zuidema, J. and Merkus, F.W.H.M., The influence of pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photoelectric registration device. Rhinol., 18 (1980) 93-104.
5. van de Donk, H.J.M., Zuidema, J. and Merkus, F.W.H.M., Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs. Rhinol., 20 (1982) 81-87.
6. Donovan, M.D., Flynn, G.L. and Amidon, G.L., The molecular weight dependence of nasal absorption: the effect of absorption enhancers. Pharm. Res., 7 (1990) 808-815.
7. Ennis, R.D., Borden, L. and Lee, W.A., The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study. Pharm. Res., 7 (1990) 468-475.
8. Gizurarson, S., The relevance of nasal physiology to the design of drug absorption studies. Advan. Drug Delic. Rev., 11 (1993) 329-347.
9. Hermens, W.A.J.J., Beider, C.W.J., Merkus, J.M.W.M. et al., Intranasal estradiol administration to oophorectomized women. Eur. J. Obs. Gynecol. Reprod. Biol., 40 (1991) 35-41.
10. Hirai, S., Yahiki, T., Tai, M. and Mima, H., Absorption of drugs from the nasal mucosa of rat. Int. J. Pharm., 7 (1981) 317-325.
11. Krishnamoorthy, R., Woika, A.M., Shao, Z. and Mitra, A.K., Cyclodextrins as mucosal absorption promoters IV. Evaluation of nasal mucotoxicity. Eur. J. Pharm. Biopharm., 41 (1995) 296-301.
12. Lee, V.H.L., Yamamoto, A. and Bhaskar Kompella, U., Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carr. Syst., 8 (1991) 91-192.
13. Marttin, E., Verhoef, J.C., Romeijn, S.G. and Merkus, F.W.H.M., Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity. Pharm. Res., 12 (1995) 1151-1157.
14. Merkus, F.W.H.M., Schipper, N.G.M., Hermens, W.A.J.J., Romeijn, S.G. and Verhoef, J.C., Absorption enhancers in nasal drug delivery: efficacy and safety. J. Control. Rel., 24 (1993) 201-208.
15. Méry, S., Gross, E.A., Joyner, D.R., Godo, M. and Morgan, K.T., Nasal diagrams: a tool for recording the distribution of nasal lesions in rat and mice. Toxicol. Pathol., 22 (1994) 353-372.
16. Pontiroli, A.E., Alberetto, M., Calderara, A., Pajetta, E. and Pozza, G., Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents, Eur. J. Clin. Pharmacol., 37 (1989) 427-430.
17. Pontiroli, A.E., Pajetta, E., Calderara, A. et al., Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study, J. Endocrinol. Invest., 14 (1991) 47-51.
18. Randall, H.W., Bogdanffy, M.S. and Morgan, K.T., Enzyme histochemistry of the rat nasal mucosa embedded in cold glycol methacrylate. Am. J. Anat., 179 (1987) 10-17.
19. Romeijn, S.G., Verhoef, J.C., Marttin, E. and Merkus, F.W.H.M., The effect of nasal drug formulations on ciliary beating in vitro, Int. J. Pharm.. 135 (1996) 137-145.
20. Shao, Z., Krishnamoorthy, R. and Mitra, A.K., Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations, Pharm. Res., 9 (1992) 1157-1163.
21. Uraih, L.C. and Maronpot, R.R., Normal histology of the nasal cavity and application of special techniques, Environ. Health Persp., 85 (1990) 187-208.